DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic GERD

Information source: Wyeth
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gastroesophageal Reflux

Intervention: pantoprazole (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth

Summary

To assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD).

Clinical Details

Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study of the Efficacy and Safety of Pantoprazole Sodium Enteric-Coated Granules in Infants (1 Through 11 Months) With Symptomatic GERD.

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: To assess the efficacy of pantoprazole in infants. The difference in withdrawal rates will be compared between the treatment and placebo groups.

Eligibility

Minimum age: N/A. Maximum age: 11 Months. Gender(s): Both.

Criteria:

Inclusion Criteria:

- term or post term infants beyond the neonatal period of an age greater than 28 days

but less than or equal to 11 months

- clinical diagnosis of GERD

- weight greater than 2. 5 kg and less than or equal to 15 kg

Exclusion Criteria:

- known history of upper GI anatomic disorders

- history of acute life-threatening medical conditions

- clinically significant medical conditions or laboratory abnormalities

Locations and Contacts

Mobile, Alabama 36604, United States

Phoenix, Arizona 85016, United States

Little Rock, Arkansas 72205, United States

Oakland, California 94609, United States

Orange, California 92868, United States

Washington, District of Columbia 20010, United States

Miami, Florida 33101, United States

Orlando, Florida 32801, United States

Tampa, Florida 33606, United States

Pensacola, Florida 32504, United States

Augusta, Georgia 30912, United States

Peoria, Illinois 61603, United States

Bardstown, Kentucky 40004, United States

Louisville, Kentucky 40202, United States

Boston, Massachusetts 02114, United States

Flint, Michigan 48503, United States

Jackson, Mississippi 39216, United States

Omaha, Nebraska 68105, United States

Las Vegas, Nevada 89109, United States

Camden, New Jersey 08103, United States

Mays Landing, New Jersey 08330, United States

Morristown, New Jersey 07962, United States

Buffalo, New York 14222, United States

Valhalla, New York 10595, United States

Brooklyn, New York 11219, United States

Durham, North Carolina 27710, United States

Cincinnati, Ohio 45229, United States

Oklahoma City, Oklahoma 73104, United States

Bethlehem, Pennsylvania 18017, United States

Memphis, Tennessee 38103, United States

Temple, Texas 76508, United States

Salt Lake City, Utah 84113, United States

Burlington, Vermont 05401, United States

Richmond, Virginia 23219, United States

Norfolk, Virginia 23507, United States

Huntington, West Virginia 25701, United States

Morgantown, West Virginia 26506, United States

Madison, Wisconsin 53715, United States

Additional Information

Starting date: September 2006
Ending date: November 2007
Last updated: December 18, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009